文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

支气管肺发育不良的肺移植

Lung Transplantation for Bronchopulmonary Dysplasia.
PubMed 文献 · Chest · 2023-01-04
一句话结论UNOS 登记显示支气管肺发育不良患者肺移植后生存与其他诊断患者相似,作者认为对进行性呼吸恶化者可考虑肺移植。

该研究查询 UNOS 登记(2000-2020 年)所有年龄列入或接受肺移植的患者,比较支气管肺发育不良(BPD)与其他诊断患者的等待名单结局及移植后 1、5、10 年生存。BPD 共报告 65 例,其中 32 例(49.2%)接受肺移植;BPD 患者列入时更年轻(中位 21 岁 vs 57 岁,P < .001),列入时机械通气比例更高(23% vs 3.7%,P < .001),FEV1 占预计值 17% vs 34%(P = .002)。BPD 患者移植后总体生存与其他诊断患者相似(P = .106),倾向性评分匹配后仍相似(P = .41)。作者结论认为现代 BPD 肺移植结局与其他人群相似,对进行性呼吸恶化者可考虑肺移植。

要点

  • BPD 患者列入肺移植时中位年龄 21 岁(四分位距 5-31 岁),其他诊断患者为 57 岁(45-63 岁),P < .001。
  • BPD 患者列入时机械通气比例 23%,其他诊断患者为 3.7%,P < .001。
  • BPD 患者 FEV1 占预计值 17%,其他诊断患者为 34%,P = .002。
  • BPD 患者肺移植后总体生存与其他诊断患者相似(P = .106),倾向性评分匹配后仍相似(P = .41)。
  • 作者认为,对进行性呼吸恶化的 BPD 患者可考虑肺移植。

适用人群与场景

  • UNOS 登记中 2000-2020 年所有年龄列入或接受肺移植的患者,比较 BPD 与其他诊断患者。
  • BPD 患者中比较了前表面活性物质时代出生(pre-SE,1990 年前)与后表面活性物质时代出生(post-SE)者的移植后生存。

研究设计与关键结果

  • 研究类型为 UNOS 登记数据库分析(2000-2020 年),BPD 共报告 65 例,其中 32 例(49.2%)接受肺移植。
  • BPD 患者列入时中位年龄 21 岁(四分位距 5-31 岁) vs 其他诊断 57 岁(45-63 岁),P < .001。
  • BPD 患者列入时机械通气比例 23% vs 其他诊断 3.7%,P < .001。
  • BPD 患者 FEV1 占预计值 17% vs 其他诊断 34%,P = .002。
  • BPD 患者移植后总体生存与其他诊断患者相似(P = .106),倾向性评分匹配后仍相似(P = .41)。

证据类型、等级与局限

  • 证据类型:UNOS 登记数据库分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对进行性呼吸恶化的 BPD 患者可考虑肺移植。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients with bronchopulmonary dysplasia (BPD) have poor respiratory trajectories and are at increased risk of lung function decline with age. Lung transplant (LTx) is a possible treatment option for this growing patient population, but little has been published on LTx in this patient group.

RESEARCH QUESTION: What are the characteristics of patients with BPD who are listed for LTx? How do waitlist and post-LTx outcomes for BPD compare with LTx for other diagnoses?

STUDY DESIGN AND METHODS: The United Network for Organ Sharing (UNOS) registry was queried for patients of all ages listed for or who underwent LTx (2000-2020). Descriptive analysis, waitlist outcomes, and post-LTx survival at 1, 5, and 10 years were assessed comparing patients with BPD vs LTx patients with other diagnoses. Post-LTx survival for patients with BPD born in the pre-surfactant era (pre-SE, before 1990) and those born in the post-surfactant era (post-SE) was compared. Propensity score matching was performed to control for the risk factors and match patients with BPD with other LTx patients on a 1:1 ratio.

RESULTS: BPD was reported in 65 patients, of whom 32 (49.2%) underwent LTx. Patients with BPD at listing were younger than those with other diagnoses (median age, 21 [interquartile range, 5-31] years vs 57 [45-63] years; P < .001), and more were likely to receive mechanical ventilation at listing (23% vs 3.7%; P < .001). Patients with BPD had an FEV1 of 17% compared with 34% predicted in other patients (P = .002). Patients with BPD had an overall similar post-LTx survival compared with patients with other diagnoses (P = .106), even following propensity score matching (P = .41).

INTERPRETATION: LTx for BPD has increased over the last 20 years. Patients with BPD have similar post-LTx outcomes compared with those of other patient populations in the modern era. Thus, LTx could be considered for patients with BPD experiencing progressive respiratory deterioration.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Dani A, Hayes D, Guzman-Gomez A, et al. Lung Transplantation for Bronchopulmonary Dysplasia. Chest. 2023. PMID: 36610665. doi:10.1016/j.chest.2022.12.032

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。